Economic and Social Impact of OAB Con J Kelleher  European Urology Supplements  Volume 1, Issue 4, Pages 11-16 (July 2002) DOI: 10.1016/S1569-9056(02)00043-X

Fig. 1 Prevalence of OAB reported in the NOBLE study [2]. OAB dry: four or more episodes of urgency in the preceding 4 weeks, and either frequency more than eight voids per day or the use of one or more coping behaviors to control bladder function. OAB wet: same criteria as OAB dry, plus three or more episodes of urinary incontinence in the past 4 weeks that could not be explained by stress symptoms. European Urology Supplements 2002 1, 11-16DOI: (10.1016/S1569-9056(02)00043-X)

Fig. 2 The prevalence of common chronic conditions in the US (dagger refers to data from [2] and asterisk refers to data from [8]). European Urology Supplements 2002 1, 11-16DOI: (10.1016/S1569-9056(02)00043-X)

Fig. 3 Model for the economic evaluation of OAB treatment. QALY: quality-adjusted life year. European Urology Supplements 2002 1, 11-16DOI: (10.1016/S1569-9056(02)00043-X)

Fig. 4 Scores generated by the Short Form (SF) 36 questionnaire in the NOBLE program. OAB dry: four or more episodes of urgency in the preceding 4 weeks, and either frequency more than eight voids per day or the use of one or more coping behaviors to control bladder function. OAB wet: same criteria as OAB dry, plus three or more episodes of urinary incontinence in the past 4 weeks that could not be explained by stress symptoms. European Urology Supplements 2002 1, 11-16DOI: (10.1016/S1569-9056(02)00043-X)

Fig. 5 Quality of life for patients with OAB, genuine stress incontinence (GSI) and normal urodynamics (UDS): cumulative mean scores for 392 women completing part II of the KHQ [20]. European Urology Supplements 2002 1, 11-16DOI: (10.1016/S1569-9056(02)00043-X)